ZEB1 and non-small cell lung carcinoma: Similarly, exposure to cisplatin or doxorubicin following GH stimulation significantly increased ZEB1 levels, and pegvisomant inhibited this induction in all NSCLC cells (Figure 7A,B,F,J,N).